List of Excipients in API trametinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing trametinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | MEKINIST | trametinib | 0078-0666 | CELLULOSE, MICROCRYSTALLINE | |
Novartis Pharmaceuticals Corporation | MEKINIST | trametinib | 0078-0666 | CROSCARMELLOSE SODIUM | |
Novartis Pharmaceuticals Corporation | MEKINIST | trametinib | 0078-0666 | FERRIC OXIDE RED | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for trametinib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
trametinib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
trametinib drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
trametinib drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
trametinib drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
trametinib drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
trametinib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
trametinib drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
trametinib drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
trametinib drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
trametinib drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
trametinib drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | trametinib | 0078-0666 |
>Company | >Ingredient | >NDC |
trametinib drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.